# Combination Chemotherapy in Treating Patients With Colon Cancer

> **NCT00046995** · PHASE3 · UNKNOWN · sponsor: **Groupe Regional d'Etudes du Cancer Colorectal** · enrollment: 800 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** fluorouracil
- **DRUG:** leucovorin calcium
- **PROCEDURE:** adjuvant therapy

## Key facts

- **NCT ID:** NCT00046995
- **Lead sponsor:** Groupe Regional d'Etudes du Cancer Colorectal
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046995, "Combination Chemotherapy in Treating Patients With Colon Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00046995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*